Vascular and biliary complications after liver transplant can be reliably diagnosed when using CE-USMay 07, 2007Contrast-enhanced ultrasound (CE-US) after a liver transplant is highly accurate in showing vascular as well as biliary complications, according to a recent study. The study consisted of 39 liver transplant recipients who underwent a CE-US exam after developing fluid in the abdomen and/or unclear liver function tests. "Acute liver failure is the most serious complication in the early post transplant period, caused by acute rejection, primary graft non-function, or vascular thrombosis," said Dirk Clevert, MD, lead author of the study. "Biliary complications occur in up to 10% of adults. The incidence is higher in children. Biliary obstruction has several causes, such as anastomotic strictures, hepatic artery thrombosis, non-anastomotic strictures, segmental biliary obstruction or bile leaks," he said. According to the study, complications were identified in 43.5% of patients. Five transplants (13 %) had hepatic artery thrombosis or significant stenosis, and seven transplants (18 %) developed portal vein stenosis or portal vein thrombosis. MRA or CTA confirmed the findings of the CE-US in all cases. "CE-US can accurately show vascular as well as biliary complications in the postoperative patient," said Dr. Clevert. "It is important to detect the complications in an early stage so patients can be treated appropriately,"he said. The full results of this study will be presented on Monday, May 7, 2007 during the American Roentgen Ray Society's annual meeting in Orlando, FL. American Roentgen Ray Society |
|||||||||||||||||||||
| Related Liver Transplant Current Events and Liver Transplant News Articles Extending treatment after liver transplant may benefit patients with hepatitis C recurrence Extending hepatitis C treatment for liver transplant patients beyond current practice results in high rates of clearance of the hepatitis C virus from the blood, as well as a low rate of relapse, according to a Henry Ford Hospital study. Lower tacrolimus doses is suitable for living donor liver transplantation with small-for-size graft Several studies have shown that living donor liver transplant (LDLT) recipients required smaller doses of tacrolimus compared with deceased donor liver transplant (DDLT) patients, which indicated that liver regeneration could affect the metabolism of tacrolimus in LDLT. First human gets new antibody aimed at hepatitis C virus Building upon a series of successful preclinical studies, researchers at MassBiologics of the University of Massachusetts Medical School (UMMS) today announced the beginning of a Phase 1 clinical trial, testing the safety and activity of a human monoclonal antibody they developed that can neutralize the Hepatitis C virus (HCV). Scientists link immune system's natural killer cells to infant liver disease Scientists have linked an overactive response by one of the immune system's key weapons against infection - natural killer, or NK, cells - to the onset of biliary atresia in infants, a disease where blocked bile ducts can cause severe liver damage and death. Mayo Clinic finds new pathology tests double sensitivity to detect bile duct and pancreatic cancers Pancreatic cancer and bile duct cancer are difficult to diagnose and often fatal because they are discovered in the advanced stages of the disease. Mayo Researchers Help Discover Genetic Cause for Primary Biliary Cirrhosis Researchers have discovered a novel molecular path that predisposes patients to develop primary biliary cirrhosis, a disease that mainly affects women and slowly destroys their livers. Primary biliary cirrhosis has no known cause. What is the function of lymph nodes? If we imagine our immune system to be a police force for our bodies, then previous work has suggested that the Lymph nodes would be the best candidate structures within the body to act as police stations - the regions in which the immune response is organised. Novel antibody prevents infection by hepatitis C virus Taking aim at a leading cause of liver failure in the United States, a team of scientists at the Massachusetts Biologic Laboratories (MBL) of the University of Massachusetts Medical School (UMMS) has developed a human monoclonal antibody that neutralizes the Hepatitis C virus (HCV). HIV positive and HIV negative patients have similar survival rates following liver transplant HIV positive and HIV negative patients have comparable survival rates following liver transplant, according to new research presented today at EASL 2009, the Annual Meeting of the European Association for the Study of Liver in Copenhagen, Denmark. Mayo Clinic's new imaging technology accurately identifies a broad spectrum of liver disease A new study shows that an imaging technology developed by Mayo Clinic researchers can identify liver fibrosis with high accuracy and help eliminate the need for liver biopsies. Liver fibrosis is a common condition that can lead to incurable cirrhosis if not treated in time. More Liver Transplant Current Events and Liver Transplant News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||